Matches in SemOpenAlex for { <https://semopenalex.org/work/W2521768219> ?p ?o ?g. }
Showing items 1 to 87 of
87
with 100 items per page.
- W2521768219 abstract "Introduction: Chemotherapy resistance is responsible for high mortality rates in high-risk neuroblastoma patients. MYCN is a major oncogenic driver in these tumors controlling pluripotency genes including LIN28B. Therefore, we hypothesized that enhanced embryonic stem cell (ESC) gene regulatory programs could mark tumors with increased risk for therapy failure enabling the selection of patients for novel targeted therapies.M&M: A microRNA expression ESC-signature was established based on publically available data. In addition, an mRNA ESC-signature of top 500 protein coding genes with highest positive correlation with the microRNA ESC-signature score was generated.Results: High ESC-signature scores were significantly correlated with worse neuroblastoma patient survival, both in the global patient cohort as well as in the subset of stage 4 tumors without MYCN-amplification. In addition, both in neuroblastoma and other embryonal tumors exhibiting MYCN-activation, the scores were significantly higher. This was confirmed in MYCN cell model systems where the scores altered upon MYCN-overexpression/knock-down. Using GSEA, we identified that genes implicated in DNA damage response and cell cycle control were strongly enriched in the signature. One of the genes in the signature is the transcription factor FOXM1, which is a master regulator driving those pathways. The upstream activator of FOXM1, MELK, was also part of the signature. Inhibition of FOXM1 in neuroblastoma cells using the small molecule FDI-6 significantly reduced cell viability. In addition, MELK inhibitors are currently tested in vitro and both FOXM1 and MELK inhibitors are evaluated in MYCN transgenic zebrafish models.Conclusion: A novel ESC-signature score marks neuroblastomas with poor prognosis enabling the identification of ultra-high-risk neuroblastoma patients that may benefit from targeted therapies using FOXM1 or MELK inhibitors." @default.
- W2521768219 created "2016-09-30" @default.
- W2521768219 creator A5016004596 @default.
- W2521768219 creator A5016474042 @default.
- W2521768219 creator A5034282785 @default.
- W2521768219 creator A5037947455 @default.
- W2521768219 creator A5059242352 @default.
- W2521768219 creator A5059398199 @default.
- W2521768219 creator A5062730954 @default.
- W2521768219 creator A5072634770 @default.
- W2521768219 creator A5079987898 @default.
- W2521768219 date "2016-01-01" @default.
- W2521768219 modified "2023-09-27" @default.
- W2521768219 title "An embryonic stem cell activated FOXM1 transcriptional program marks ultra-high-risk primary neuroblastoma patients for FDI-6 small molecule inhibition" @default.
- W2521768219 hasPublicationYear "2016" @default.
- W2521768219 type Work @default.
- W2521768219 sameAs 2521768219 @default.
- W2521768219 citedByCount "0" @default.
- W2521768219 crossrefType "journal-article" @default.
- W2521768219 hasAuthorship W2521768219A5016004596 @default.
- W2521768219 hasAuthorship W2521768219A5016474042 @default.
- W2521768219 hasAuthorship W2521768219A5034282785 @default.
- W2521768219 hasAuthorship W2521768219A5037947455 @default.
- W2521768219 hasAuthorship W2521768219A5059242352 @default.
- W2521768219 hasAuthorship W2521768219A5059398199 @default.
- W2521768219 hasAuthorship W2521768219A5062730954 @default.
- W2521768219 hasAuthorship W2521768219A5072634770 @default.
- W2521768219 hasAuthorship W2521768219A5079987898 @default.
- W2521768219 hasConcept C104317684 @default.
- W2521768219 hasConcept C145059251 @default.
- W2521768219 hasConcept C145103041 @default.
- W2521768219 hasConcept C150194340 @default.
- W2521768219 hasConcept C162317418 @default.
- W2521768219 hasConcept C170240278 @default.
- W2521768219 hasConcept C2776715637 @default.
- W2521768219 hasConcept C2777956278 @default.
- W2521768219 hasConcept C2779102060 @default.
- W2521768219 hasConcept C2779733811 @default.
- W2521768219 hasConcept C28328180 @default.
- W2521768219 hasConcept C29537977 @default.
- W2521768219 hasConcept C502942594 @default.
- W2521768219 hasConcept C54355233 @default.
- W2521768219 hasConcept C81885089 @default.
- W2521768219 hasConcept C86803240 @default.
- W2521768219 hasConceptScore W2521768219C104317684 @default.
- W2521768219 hasConceptScore W2521768219C145059251 @default.
- W2521768219 hasConceptScore W2521768219C145103041 @default.
- W2521768219 hasConceptScore W2521768219C150194340 @default.
- W2521768219 hasConceptScore W2521768219C162317418 @default.
- W2521768219 hasConceptScore W2521768219C170240278 @default.
- W2521768219 hasConceptScore W2521768219C2776715637 @default.
- W2521768219 hasConceptScore W2521768219C2777956278 @default.
- W2521768219 hasConceptScore W2521768219C2779102060 @default.
- W2521768219 hasConceptScore W2521768219C2779733811 @default.
- W2521768219 hasConceptScore W2521768219C28328180 @default.
- W2521768219 hasConceptScore W2521768219C29537977 @default.
- W2521768219 hasConceptScore W2521768219C502942594 @default.
- W2521768219 hasConceptScore W2521768219C54355233 @default.
- W2521768219 hasConceptScore W2521768219C81885089 @default.
- W2521768219 hasConceptScore W2521768219C86803240 @default.
- W2521768219 hasLocation W25217682191 @default.
- W2521768219 hasOpenAccess W2521768219 @default.
- W2521768219 hasPrimaryLocation W25217682191 @default.
- W2521768219 hasRelatedWork W2044074021 @default.
- W2521768219 hasRelatedWork W2054013802 @default.
- W2521768219 hasRelatedWork W2099763952 @default.
- W2521768219 hasRelatedWork W2130940803 @default.
- W2521768219 hasRelatedWork W2145927254 @default.
- W2521768219 hasRelatedWork W2199123913 @default.
- W2521768219 hasRelatedWork W2402234250 @default.
- W2521768219 hasRelatedWork W2522275245 @default.
- W2521768219 hasRelatedWork W2616491757 @default.
- W2521768219 hasRelatedWork W2623830154 @default.
- W2521768219 hasRelatedWork W2741920589 @default.
- W2521768219 hasRelatedWork W2762946638 @default.
- W2521768219 hasRelatedWork W2890518643 @default.
- W2521768219 hasRelatedWork W2902353965 @default.
- W2521768219 hasRelatedWork W2954674403 @default.
- W2521768219 hasRelatedWork W2989845132 @default.
- W2521768219 hasRelatedWork W3037554603 @default.
- W2521768219 hasRelatedWork W3126881324 @default.
- W2521768219 hasRelatedWork W3158639418 @default.
- W2521768219 hasRelatedWork W751865729 @default.
- W2521768219 isParatext "false" @default.
- W2521768219 isRetracted "false" @default.
- W2521768219 magId "2521768219" @default.
- W2521768219 workType "article" @default.